Printer Friendly

THE CREATION OF A LIVING LABORATORY FOR OPTIMAL ARTHRITIS CARE: SAN MATEO ARTHRITIS PROJECT ANNOUNCED

 THE CREATION OF A LIVING LABORATORY FOR OPTIMAL ARTHRITIS CARE:
 SAN MATEO ARTHRITIS PROJECT ANNOUNCED
 WHAT: Press conference announcing the establishment of a National Community Model for improving the lives of Americans with arthritis -- with expert presentations, video of people with arthritis relating their personal experiences and demonstrating tools for improving function, and a bicoastal discussion period with the press.
 SmithKline Beecham will also describe the science and clinical profile of the new medication Relafen.
 WHEN: March 19, 1992, at Noon (EST) and 9 a.m. Pacific time.
 WHERE: The project will be announced and described at a two-site satellite teleconference.
 Attention Television Stations: The press conference can be picked up on KU Band satellite noon EST to 1 p.m. EST, N.Y. portion is on G-Star 3, Transponder 16, San Mateo Portion is on G-Star 3, Transponder 9, with Audio for both locations on 6.2 and 6.8.
 -- Technical Note: Updated tracking information on G-Star 3 can be accessed from GTE, 800-772-2363.
 B-Roll can be picked up on C-Band satellite 2:30-3:30 p.m. EST, on Westar 5, Transponder 24, Audio 6.2 and 6.8.
 In New York In San Mateo, Calif.
 The St. Regis City Hall
 2 East 55th St. 330 West 20th Ave.
 WHO: -- Arthur Grayzel, MD, senior vice president, Medical Affairs
 Arthritis Foundation.
 -- J.P. Garnier, president, SmithKline Beecham
 -- Florence Rhoads, mayor, San Mateo
 -- Gerson Bernhard, MD, medical director
 -- Arthritis Center at Mills-Peninsula Hospitals
 -- Wilbur Blechman, MD, University of Miami School of Medicine
 -- National and Local leaders of the Arthritis Foundation
 -- People with arthritis
 For more information and to register call the contact below.
 CONTACT: Holly Eger of San Mateo Arthritis Project, 415-433-5381, or Sharon Kroll of Edelman, 212-704-8245, for San Mateo
 -0- 3/17/92


CO: San Mateo Arthritis Project ST: California IN: HEA SU:

TS-OS -- NY055 -- 8789 03/17/92 12:57 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 17, 1992
Words:313
Previous Article:WARNER NOMINATED TO ANHEUSER-BUSCH COMPANIES BOARD
Next Article:NABORS INDUSTRIES ANNOUNCES APPOINTMENT OF DENNIS SMITH AS PRESIDENT OF SUBSIDIARY
Topics:


Related Articles
SAN MATEO, CALIF., NAMED NATIONAL SITE FOR MODEL ARTHRITIS CARE PROJECT
RELAFEN AVAILABLE IN THE UNITED STATES: NEW CLASS OF NSAID WITH LOW ULCER INCIDENCE
FREE ARTHRITIS FOUNDATION MEMBERSHIPS ARE OFFERED, COMPLIMENTS OF SMITHKLINE BEECHAM
NAPRELAN, ONCE-A-DAY FORMULATION OF NAPROXEN CLEARED FOR MARKETING BY FDA, ELAN CORPORATION AND WYETH AYERST ANNOUNCE
Arthritis Foundation Announces New Agreement With McNeil Consumer Products Company
New 500 mg Tablet of Lodine(R) XL Receives FDA Clearance
Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in Patients.
Study Finds That New Laboratory Tests From Prometheus Laboratories May Enable Doctors to Individualize Rheumatoid Arthritis Therapy.
Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in Patients; -- Free Garden-Themed Seminars throughout the Country Educate Patients...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters